Reaction

Facial Dysmorphism reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 221 reports · 4 co-occurring drugs

As of the last recalculation, Facial Dysmorphism appears in 221 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is VALPROATE SODIUM (PRR 146.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Valproate Sodium28146.0146.2
Nevirapine664.464.4
Efavirenz652.152.1
Vigabatrin639.839.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.